Valvular & structural heart disease
Lifetime exercise dose and ventricular arrhythmias in patients with mitral valve prolapse
Authors' conclusion
We found no clear association between moderate lifetime exercise dose and severe VA in patients with MVP.
Study context
- Population
- Patients with mitral valve prolapse (MVP)61% female
- Participants
- 136 patients
- Exposure
- Severe VA vs no severe VA
- Severe VAn = 17
- Outcome
- Association of lifetime exercise dose (MET h/week) with severe VA
Main finding
As reported in the abstract
Lifetime exercise dose
P = 0.34
Observational data: associations, not effects.
Further findings
Lifetime exercise dose > 9.6 metabolic equivalents of task (MET) h/week as marker for severe VA
| OR (95% CI) | P value | ||
|---|---|---|---|
| > 9.6 MET h/weekUnadjusted; borderline significant | 3.38 (0.92–12.40) | P = 0.07 | |
| > 9.6 MET h/weekAdjusted for age | 2.63 (0.66–10.56) | P = 0.17 | |
| 0.050.21520Odds ratio (log scale) |
Circumstances at VA event
- Wakeful rest
- 53%
- Exercise
- 29%
- Sleep
- 12%
Original publication
Lifetime exercise dose and ventricular arrhythmias in patients with mitral valve prolapse. Europace. Published 18 October 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →